Summary Takeaways:
Payment misalignment in Medicare FFS for Substance Use Disorder
(SUD) treatment as the subject of potential legislative and/or
regulatory reforms
New opportunities for investor-backed behavioral health
platforms in Medicare Advantage and other value-based
arrangements
New possible focus areas for health plans with expertise in
Medicaid managed care to expand into Medicare managed care models
for SUD treatment
The opioid epidemic has been further fueled by the COVID-19
pandemic and a recently published report by the Legal Action Center
(entitled Medicare Coverage of Substance Use Disorder Care:
A Landscape Review of Benefit Coverage, Service Gaps, and a Path to
Advertisement
COVID-19 Compounds Opioid Crisis and Treatment Gaps for Vulnerable Americans: Will a Biden Administration and New Congress Expand Medicare Coverage? Wednesday, March 3, 2021
Summary Takeaways:
Payment misalignment in Medicare FFS for Substance Use Disorder (SUD) treatment as the subject of potential legislative and/or regulatory reforms
New opportunities for investor-backed behavioral health platforms in Medicare Advantage and other value-based arrangements
New possible focus areas for health plans with expertise in Medicaid managed care to expand into Medicare managed care models for SUD treatment
The opioid epidemic has been further fueled by the COVID-19 pandemic and a recently published report by the Legal Action Center (entitled Medicare Coverage of Substance Use Disorder Care: A Landscape Review of Benefit Coverage, Service Gaps, and a Path to Reform) (the Report) shines a light on the shortcomings of Medicare to provide critically needed access
Payment misalignment in Medicare FFS for Substance Use Disorder (SUD) treatment as the subject of potential legislative and/or regulatory reforms - New opportunities for.